Part:BBa_K3661007
Hiracin JM79 have been tested and reported to have activity against enterococcus faecalis.[1] A major benefit of the Hiracin JM79 as an antimicrobial agent is their specificity compared to many traditional antibiotics.
Contents
Usage
In 2020 CPU_CHINA project, Hiracin JM79 were used to kill entrococcus faecalis. Hiracin JM79 can be secreted from engineered bacteria to increase the extracellular concentration. Bacteriocins thus improve ALD in patients by killing enterococcus faecalis in the cellular environment.
Biology
Bacteriocins are proteinaceous or peptidic toxins produced by bacteria to inhibit the growth of similar or closely related bacterial strain(s). Hiracin JM79 (HirJM79), a Sec-dependent bacteriocin produced by enterococcus hirae DCH5, was proved to have activity against enterococcus faecalis.
Characterization
Plasmid (YebF-Hiracin JM79-flag) was transfected into E.coli BL21(DE3). Hiracin JM79 was secreted from the engineered bacteria through YebF secretion system. In order to determine whether Hiracin JM79 was successfully expressed in the cellular environment , we performed Elisa of flag protein. Then we calculated the amount of Hiracin JM79 based on the expression of flag protein.
The sample group was significantly different compared to the negative control group.*P < 0.05, ** P < 0.01, *** P < 0.001, and ****P < 0.0001 by t test.
Reference
[1]Sánchez, J., Diep, D. B., Herranz, C., Nes, I. F., Cintas, L. M., & Hernández, P. E. (2007). Amino acid and nucleotide sequence, adjacent genes, and heterologous expression of hiracin JM79, a sec-dependent bacteriocin produced by Enterococcus hirae DCH5, isolated from Mallard ducks (Anas platyrhynchos). FEMS microbiology letters, 270(2), 227–236. https://doi.org/10.1111/j.1574-6968.2007.00673.x
None |